Citadel’s motion to dismiss has now been denied in NWBO case
Comments Off on Citadel’s motion to dismiss has now been denied in NWBO case
The legal battle involving Citadel and NWBO continues as the court denies a motion to dismiss allegations of market manipulation.
Citadel, Virtu, Susquehanna Fight Biotech Company Lawsuit
Citadel and 7 other market makers have jointly filed motion to dismiss the lawsuit issued by cancer research company Northwest Therapeutics.
NWBO Stock: Citadel Chooses to Profit from Cancer Drug Company
Citadel Securities has chosen to profit from shorting NWBO stock. Now more and more companies are getting together to fight manipulation.
